KEYNOTE-355: Final results from a randomized, double-blind phase III study of first-line pembrolizumab plus chemotherapy vs placebo plus chemotherapy for metastatic TNBC

被引：54

作者：

Cortes, J. ^{[1
,2
,3
,4
]}

Cescon, D. W. ^{[5
]}

Rugo, H. S. ^{[6
]}

Im, S-A. ^{[7
]}

Yusof, M. Md ^{[8
]}

Gallardo, C. ^{[9
]}

Lipatov, O. ^{[10
]}

Barrios, C. H. ^{[11
]}

Perez-Garcia, J. ^{[1
]}

Iwata, H. ^{[12
]}

Masuda, N. ^{[13
]}

Otero, M. Torregroza ^{[14
]}

Gokmen, E. ^{[15
]}

Loi, S. ^{[16
,17
]}

Guo, Z. ^{[18
]}

Zhou, X. ^{[18
]}

Karantza, V. ^{[18
]}

Pan, W. ^{[18
]}

Schmid, P. ^{[19
]}

机构：

[1] Int Breast Canc Ctr IBCC, Quiron Grp, Madrid, Spain

[2] Int Breast Canc Ctr IBCC, Quiron Grp, Barcelona, Spain

[3] Vall dHebron Inst Oncol, Barcelona, Spain

[4] Univ Europea Madrid, Fac Biomed & Hlth Sci, Dept Med, Madrid, Spain

[5] Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON, Canada

[6] Univ Calif San Francisco, Ctr Comprehens Canc, Dept Hematol Oncol, San Francisco, CA 94143 USA

[7] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea

[8] Pantai Hosp, Ctr Canc, Kuala Lumpur, Malaysia

[9] Arturo Lopez Perez Fdn, Inst Oncol, Santiago, Chile

[10] Republican Clin Oncol Dispensary, Dept Oncol, Republic Bashkortostan, Russia

[11] Pontificia Univ Catolica Rio Grande do Sul, Oncol Res Unit, Hosp Sao Lucas, Porto Alegre, RS, Brazil

[12] Aichi Canc Ctr Hosp, Dept Breast Oncol, Nagoya, Aichi, Japan

[13] Natl Hosp Org Osaka Natl Hosp, Breast Oncol, Dept Surg, Osaka, Japan

[14] Oncomedica SA, Hematol & Oncol, Monteria, Colombia

[15] Ege Univ, Fac Med, Sch Med, Izmir, Turkey

[16] Peter MacCallum Canc Ctr, Div Canc Res, Melbourne, Vic, Australia

[17] Univ Melbourne, Sir Peter MacCallum Dept Med Oncol, Parkville, Vic, Australia

[18] Merck & Co Inc, Merck Res Labs, Kenilworth, NJ USA

[19] Ctr Expt Canc Med, Barts Canc Inst, London, England

来源：

ANNALS OF ONCOLOGY | 2021年 / 32卷

关键词：

D O I：

10.1016/j.annonc.2021.08.2089

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LBA16

引用

页码：S1289 / S1290

页数：2